Low-Dose Oral Granisetron (1 mg) plus Intravenous Dexamethasone: Efficacy in Gynecologic Cancer Patients Receiving Carboplatin-Based Chemotherapy

By Markman M.   Kennedy A.   Webster K.   Kulp B.   Peterson G.   Belinson J.  

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 113-115

Elsevier

Access to resources Recommend Favorite

A Double-blind, Randomised Comparison of the Anti-emetic Efficacy of Two Intravenous Doses of Dolasetron Mesilate and Granisetron in Patients Receiving High Dose Cisplatin Chemotherapy

By on behalf of the European Dolasetron Comparative Study Group   Audhuy B.   Cappelaere P.   Martin M.   Cervantes A.   Fabbro M.   Riviere A.   Khayat D.   Bleiberg H.   Faraldi M.   Claverie N.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 807-813

Elsevier

Access to resources Recommend Favorite

Hypersensitivity Reactions and the Utility of Oral and Intravenous Desensitization in Patients with Gynecologic Malignancies

By Robinson J.B.   Singh D.   Bodurka-Bevers D.C.   Wharton J.T.   Gershenson D.M.   Wolf J.K.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 550-558

Elsevier

Access to resources Recommend Favorite

Effectiveness of Serotonin-Receptor Antagonist Antiemetic Therapy over Successive Courses of Carboplatin-Based Chemotherapy

By Markman M.R.   Peterson G.   Kulp B.   Markman M.  

Gynecologic Oncology, Vol. 85, Iss. 3, 2002-06 ,pp. : 435-437

Academic Press

Access to resources Recommend Favorite

Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy

By Herrstedt J.   Sigsgaard TC   Nielsen HA   Handberg J.   Langer SW   Ottesen S.   Dombernowsky P.  

Supportive Care in Cancer, Vol. 15, Iss. 4, 2007-04 ,pp. : 417-426

Springer Publishing Company

Access to resources Recommend Favorite